148 related articles for article (PubMed ID: 33397240)
1. Growth Differentiation Factor-15 as a Biomarker of Obese Pre-diabetes and Type 2 Diabetes Mellitus in Indian Subjects: A Case-control Study.
Roy D; Purohit P; Modi A; Khokhar M; Shukla RKG; Chaudhary R; Sankanagoudar S; Sharma P
Curr Diabetes Rev; 2022; 18(1):e010321189862. PubMed ID: 33397240
[TBL] [Abstract][Full Text] [Related]
2. Significant increase of serum extracellular vesicle-packaged growth differentiation factor 15 in type 2 diabetes mellitus: a cross-sectional study.
Zhao W; Li X; Li X; Peng L; Li Y; Du Y; He J; Qin Y; Zhang H
Eur J Med Res; 2023 Jan; 28(1):37. PubMed ID: 36658625
[TBL] [Abstract][Full Text] [Related]
3. GDF15 Is a Novel Biomarker for Impaired Fasting Glucose.
Hong JH; Chung HK; Park HY; Joung KH; Lee JH; Jung JG; Kim KS; Kim HJ; Ku BJ; Shong M
Diabetes Metab J; 2014 Dec; 38(6):472-9. PubMed ID: 25541611
[TBL] [Abstract][Full Text] [Related]
4. A clinical and in-silico study of microRNA-21 and growth differentiation factor-15 expression in pre-diabetes, type 2 diabetes and diabetic nephropathy.
Agarwal RG; Khokhar M; Purohit P; Modi A; Bajpai NK; Bohra GK; Garg MK; Sharma P
Minerva Endocrinol (Torino); 2023 Jun; 48(2):172-185. PubMed ID: 35103454
[TBL] [Abstract][Full Text] [Related]
5. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes.
He X; Su J; Ma X; Lu W; Zhu W; Wang Y; Bao Y; Zhou J
Cardiovasc Diabetol; 2020 Mar; 19(1):40. PubMed ID: 32222153
[TBL] [Abstract][Full Text] [Related]
6. Fıbroblast growth factor 21 and ıts relatıonshıp wıth ınsulın sensıtıvıty ın fırst-degree relatıves of patıents wıth type 2 dıabetes mellıtus.
Ors D; Eroglu Altinova A; Yalçın MM; Gulbahar O; Akturk M; Arslan M; Balos Toruner F
Endokrynol Pol; 2016; 67(3):260-4. PubMed ID: 26884286
[TBL] [Abstract][Full Text] [Related]
7. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum TNF-
Alzamil H
J Obes; 2020; 2020():5076858. PubMed ID: 32089876
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
11. Circulating expression levels of CircHIPK3 and CDR1as circular-RNAs in type 2 diabetes patients.
Rezaeinejad F; Mirzaei A; Khalvati B; Sabz G; Alipoor B
Mol Biol Rep; 2022 Jan; 49(1):131-138. PubMed ID: 34731367
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes.
Vadini F; Simeone PG; Desideri G; Liani R; Tripaldi R; Ciotti S; Tartaro A; Guagnano MT; Di Castelnuovo A; Cipollone F; Consoli A; Santilli F
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2685-2692. PubMed ID: 34226120
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus.
Zhao Z; Li X; Jian D; Hao P; Rao L; Li M
Acta Diabetol; 2017 Mar; 54(3):237-245. PubMed ID: 27878383
[TBL] [Abstract][Full Text] [Related]
14. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
15. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):213-9. PubMed ID: 17803693
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass.
Catalán V; Gómez-Ambrosi J; Ramirez B; Rotellar F; Pastor C; Silva C; Rodríguez A; Gil MJ; Cienfuegos JA; Frühbeck G
Obes Surg; 2007 Nov; 17(11):1464-74. PubMed ID: 18219773
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Plasma Growth Differentiation Factor 15 Levels and Complications of Type 2 Diabetes Mellitus: A Cross-sectional Study.
Zhu X; Zhang Y; Liang F; Yin J; Jiang L; Cai W; Lu J; Zhang C; Xiao Y; Teng H; Ge W; Hu Y; Lu Y; Su J; Zhang J; Wu M
Can J Diabetes; 2023 Mar; 47(2):117-123.e7. PubMed ID: 36526573
[TBL] [Abstract][Full Text] [Related]
18. Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Nadwa EH; Albogami SM; Alorabi M; Saad HM; Batiha GE
J Diabetes; 2022 Dec; 14(12):806-814. PubMed ID: 36444166
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus.
Spiller S; Blüher M; Hoffmann R
Diabetes Obes Metab; 2018 Nov; 20(11):2661-2669. PubMed ID: 29943387
[TBL] [Abstract][Full Text] [Related]
20. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
